Clinical trial / 2016
Broccoli sprout homogenate increased LAIV-induced granzyme B production in peripheral blood NK cells compared to placebo in healthy volunteers.
Researchers conducted a randomized, double-blind, placebo-controlled trial to evaluate whether broccoli sprout homogenates (BSH, N = 13) altered peripheral blood immune responses compared to alfalfa sprout homogenate placebo (ASH, N = 16) following nasal LAIV inoculation. LAIV significantly reduced NKT and T cell populations, decreased NK cell CD56 and CD158b expression, and increased CD16 expression and cytotoxic potential on day 2. Compared to ASH, BSH supplementation further increased LAIV-induced granzyme B production in NK cells on day 2. Additionally, granzyme B levels appeared to be negatively associated with influenza RNA levels in nasal lavage fluid cells within the BSH group.
- Study type
- Randomized, double-blind, placebo-controlled study
- Who was studied
- Healthy non-smoking volunteers (N = 13 BSH, N = 16 ASH)
- What was measured
- Peripheral blood immune cell responses, NK cell markers, and cytotoxic potential following LAIV inoculation
THE PAPER
Effect of Broccoli Sprouts and Live Attenuated Influenza Virus on Peripheral Blood Natural Killer Cells: A Randomized, Double-Blind Study.
Müller L, Meyer M, Bauer RN, Zhou H, Zhang H, Jones S, Robinette C, Noah TL, Jaspers I. PLoS One, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.